CR20250037A - CYCLIN-DEPENDENT KINASE INHIBITORS (DIVISIONAL 2020-0503) - Google Patents

CYCLIN-DEPENDENT KINASE INHIBITORS (DIVISIONAL 2020-0503)

Info

Publication number
CR20250037A
CR20250037A CR20250037A CR20250037A CR20250037A CR 20250037 A CR20250037 A CR 20250037A CR 20250037 A CR20250037 A CR 20250037A CR 20250037 A CR20250037 A CR 20250037A CR 20250037 A CR20250037 A CR 20250037A
Authority
CR
Costa Rica
Prior art keywords
cyclin
divisional
kinase inhibitors
dependent kinase
compounds
Prior art date
Application number
CR20250037A
Other languages
Spanish (es)
Inventor
Robert Steven Kania
Sajiv Krishnan Nair
Gary Michael Gallego
Sacha Ninkovic
Cynthia Louise Palmer
Suvi Tuula Marjukka Orr
Ping Chen
Judith Gail Deal
Mehran Jalaie
Sujin Cho-Schultz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB2019/053314 external-priority patent/WO2019207463A1/en
Publication of CR20250037A publication Critical patent/CR20250037A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se relaciona con compuestos de la Fórmula (I) 5 (I), 10 o una sal farmacéuticamente aceptable del mismo, en la cual los grupos-R R1 a R23, A, Q, U, V, W, X, Y, Z, n, p y q son como se definen en la presente, con composiciones farmacéuticas que comprenden tales compuestos y sales, y con métodos para utilizar tales compuestos, sales y composiciones 15 para el tratamiento de crecimiento celular anormal, que incluye cáncer, en un sujeto.This invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof, in which the R-groups R1 to R23, A, Q, U, V, W, X, Y, Z, n, p and q are as defined herein, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject.

CR20250037A 2018-03-29 2019-04-22 CYCLIN-DEPENDENT KINASE INHIBITORS (DIVISIONAL 2020-0503) CR20250037A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862826609P 2018-03-29 2018-03-29
US201862663096P 2018-04-26 2018-04-26
US201862750454P 2018-10-25 2018-10-25
PCT/IB2019/053314 WO2019207463A1 (en) 2018-04-26 2019-04-22 2-amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors

Publications (1)

Publication Number Publication Date
CR20250037A true CR20250037A (en) 2025-03-19

Family

ID=95706353

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20250037A CR20250037A (en) 2018-03-29 2019-04-22 CYCLIN-DEPENDENT KINASE INHIBITORS (DIVISIONAL 2020-0503)

Country Status (1)

Country Link
CR (1) CR20250037A (en)

Similar Documents

Publication Publication Date Title
PY1932509A (en) CYCLINE-DEPENDENT KINASE INHIBITORS
CL2019000368A1 (en) CDK2 / 4/6 inhibitors.
DOP2021000154A (en) 3-CARBONYLAMINE-5-CYCLOPENTIL-1H-PIRAZOLE COMPOUNDS THAT HAVE INHIBITORY ACTIVITY IN CDK2
CO2019009423A2 (en) Piperidine Substituted MNK Inhibitors and Related Methods
CL2019002777A1 (en) Compounds that inhibit the mcl-1 protein.
PY1996328A (en) AZALACTAM COMPOUNDS AS HPK1 INHIBITORS
MX375323B (en) MITOGEN-ACTIVATED PROTEIN KINASE (MNK) INTERACTING KINASE INHIBITORS AND METHODS RELATED THERETO.
ECSP17026210A (en) SUBSTITUTE AMINOPURINE COMPOSITIONS, COMPOSITIONS OF THE SAME, AND TREATMENT METHODS THEREOF
CR20200484A (en) SUBSTITUTE DIHYDROISOQUINOLINONE COMPOUNDS (Divisional 2016-0574)
MX379155B (en) COMPOUNDS THAT INHIBIT THE MCL-1 PROTEIN.
MX2017009824A (en) Substituted triazoles and methods relating thereto.
MX2021009426A (en) Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer.
ECSP16083017A (en) DERIVATIVES OF DIHETEROCICLO LINKED TO CYCLOALKYL
CO2019013254A2 (en) 5,6-fused bicyclic compounds and compositions for the treatment of parasitic diseases
CR20250037A (en) CYCLIN-DEPENDENT KINASE INHIBITORS (DIVISIONAL 2020-0503)
CR20240216A (en) NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER
CR20190110A (en) Substituted thiazolo-pyridine compounds as malt1 inhibitors
AR131945A1 (en) HYDROQUINAZOLINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER